Webcasts: Formulation

ASDs by Spray Drying: Process Development & Scale-Up

Webinar Date/Time: Session 1: Tuesday, February 28th , 2023 at 4pm GMT | 11am EDT | 5pm CEST Session 2: Wednesday, March 22nd, 2023 4:00pm GMT | 11:00 am EDT | 5:00 pm CEST Session 3: Thursday, April 20th, 2023 at 4 GMT | 11am EDT | 5pm CEST

Amorphous Solid Dispersions by Spray Drying: From Early Formulation to Commercial Lifecycle Management

Webinar Date/Time: Session 1: Evaluating the Best Formulations for Amorphous Solid Dispersions by Spray Drying: Tuesday, February 28th, 2023 4:00pm GMT | 11:00 am EDT | 5:00 pm CEST Session 2: ASDs by Spray Drying: Process Development & Scale-Up: Wednesday, March 22nd, 2023 at 4pm GMT | 11am EDT | 5pm CEST Session 3: Commercial Reality and Lifecycle Management of ASDs: Thursday, April 20th, 2023 at 4 GMT | 11am EDT | 5pm CEST

Effective Strategies for Pediatric Formulation Development

Thursday, November 17, 2022 at 10 am EDT | 9 am PDT | 6 am CDT In this webcast, panel speakers will discuss the unmet needs within the pediatric population, swallowability challenges related to children’s medications and strategies to optimize pediatric formulation development resulting in improved acceptability and patient treatment plans.

Successful Phase 1 Adaptive Trials: Through the Lens of Clinical Operations, Formulation Development, and Regulatory Compliance

Tuesday, October 11, 2022 at 11am EDT | 10am CDT | 8am PDT Learn how integrated formulation and clinical manufacturing expertise, as well as strategic partnerships between CDMOs and CROs, can help achieve flexible and efficient first-in-human studies, fast development of challenging molecules, and reduced clinical development timelines and costs, all while increasing success rates.

Trends in Peptides and Oligonucleotides: Choosing a Partner CDMO

Thursday, September 8, 2022 at 11am EDT; 4pm GMT; 5pm CEST This webinar will highlight the new solubility enhancing Dispersome® technology, which is based on the amorphous stabilization of a given drug using the protein beta-lactoglobulin (BLG) as novel pharmaceutical excipient. Several relevant case studies are presented to showcase the potential of this new technology. Subsequently, the webinar provides a roadmap on how these formulations can be manufactured on a commercial scale. The webinar will also cover the manufacturing of the formulations.

Capsule formulations to improve delivery of poorly absorbable drugs

Wednesday March 2, 2022 at 11am EST | 4pm GMT | 5pm CET Compounds that are poorly soluble in water are still prevalent in the pharmaceutical industry drug development pipeline. Enabling technologies such as lipid-based formulations (LBF) and amorphous solid dispersions (ASDs) can address these bioavailability limitations, enabling the creation of effective drug products.

Utilizing the GPEx® suite of technologies for cell line development and biomanufacturing of difficult-to-express proteins

On Demand Webcast Nanoparticles have unique properties that are manipulated to create novel solutions, such as innovative drug delivery systems seen in today’s Covid-19 mRNA vaccines. This webinar explores the analytical techniques used for nanoparticle characterization and its growing significance in drug delivery systems.